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SUMMARY
Objective: Ureteral stents are frequently used in gynecologic oncology. We report a cervical cancer patient
who had the complication of a vesicovaginorectal stone caused by a retained double-J stent.
Case Report: A 67-year-old woman was admitted to the hospital because of urinary leakage from the vagina
and anus. She had undergone a radical hysterectomy and radiotherapy for cervical cancer 10 years previously.
At colostomy, a right double-J stent was inserted due to intestinal obstruction and right hydronephrosis 1
year after radiotherapy. At admission, physical examination revealed a huge stone in the vagina and anus.
Plain abdominal film showed a double-J stent and a stone in the bladder. Computerized tomography showed
a communicating stone in the bladder, vagina, and anus. Cystoscopy confirmed the diagnosis of a vesico-
vaginorectal stone and a retained double-J stent. The stone and double-J stent were removed by endoscopic
cystolithotripsy, and the patient was discharged after an uneventful recovery.
Conclusion: The present case showed that a retained double-J stent following gynecologic surgery can lead
to significant morbidity. We suggest close follow-up of the inserted double-J stent in order to prevent
complications caused by its retention. [Taiwanese J Obstet Gynecol 2004;43(3):179–181]
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Introduction
The use of ureteral stents has become frequent in gyne-
cologic oncology [1]. The advantages include ensuring
passage of urine during the immediate postoperative
period, and permitting the recording of the output
of each kidney separately, if required. Ureteral stents
can also allow identification of the ureters and prevent
inadvertent ureteral injury during open surgery or lapa-
roscopic procedures. With such widespread use, com-
plications have been noted, such as migration, infec-
tion, pyelonephritis, breakage, encrustation, and stone
formation. Here, we present a patient with a huge
vesicovaginorectal stone caused by a retained double-J
stent following radical hysterectomy and radiotherapy
for cervical cancer.
Case Report
The patient was a 67-year-old woman who suffered
from urinary leakage from the vagina and anus for 2
years. She had undergone radical hysterectomy and
radiotherapy for cervical cancer 10 years previously. A
colostomy was performed and a right double-J stent
was inserted due to intestinal obstruction and right
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hydronephrosis 1 year after radiotherapy. She was ad-
mitted because of anal discomfort and urinary leakage
from the vagina and anus. At admission, physical exam-
ination revealed a stone in the vagina (Figure 1) and
anus (Figure 2). Plain abdominal film showed a double-
J stent and a huge stone in the bladder (Figure 3).
Computerized tomography showed a communicat-
ing stone in the bladder, vagina, and anus. A stone
caused by a retained stent was thus suspected. Cysto-
scopy confirmed the diagnosis of a vesicovaginorec-
tal stone and a retained double-J stent. The stone and
stent were removed by endoscopic cystolithotripsy.
After surgery, she received medical treatment and
her symptoms improved. She was discharged 1 week
later after an uneventful recovery.
Discussion
There were two main causes of stone formation in this
case. First, the long period that the double-J stent was
Figure 1. Vesicovaginorectal stone in the vagina.
Figure 2. Vesicovaginorectal stone in the anus. Figure 3. Double-J stent and a huge stone in the bladder.
present and, second, the fact that the polyurethane of
the ureteral stent encourages material to be deposited.
Forgotten ureteral stents can lead to significant morbidity
[2–4]. The optimum interval for change or removal of a
ureteral stent is between 2 and 4 months [3]. Insertion
of ureteral stents is often associated with alkaline urine,
urinary infection, and predominantly calcium phosphate
deposits. The etiology of encrustation is not completely
clear. Risk factors include a history of urolithiasis, urinary
tract infection, and prolonged stenting [3]. El-Faqih et
al evaluated 299 stents in patients with calculi and
noted an encrustation rate of 9.2% before 6 weeks,
47.5% from 6 to 12 weeks, and 76.3% after 12 weeks [2].
In this case, the stent had been present for more than 1
year, and a stone caused by the retained stent was thus
suspected.
Two major materials are used in stents: polyurethane
and silicone. In our case, a polyurethane stent was used.
Polyurethane is a material that easily accepts deposits;
polyurethane stents are four times less likely to break
than silicone stents, but microscopic irregularities can
predispose them to encrustation [5]. Silicone stents
may be advantageous due to a lower risk of calcification
and prolonged maintenance of tensile strength for up
to 20 months. However, their smooth regular surface
renders them susceptible to migration [6]. If ureteral
stents are to be left for a long time, silicone stents may
be a better choice than polyurethane stents.
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Stone formation most frequently occurs at the
vesical end of the ureteral stent [2]. Management of
complicated stents requires coordinated use of medi-
cal, lithotripsy, and endourologic techniques. We had
three choices of therapy in this case: drugs, extracor-
poreal shock wave lithotripsy (ESWL), and electro-
hydraulic lithotripsy. Dissolution of struvite and car-
bonate apatite calcifications on urethral catheters and
ureteral stents using oral acetohydroxamic acid or
hemiacridin irrigation has been reported [7]. Lupu et
al described ESWL as the noninvasive procedure of
choice for calcified ureteral stents [8]. Although ESWL
successfully fragmented calcifications at the renal end
and lower ureteral segments, electrohydraulic litho-
tripsy was necessary to fragment calcifications at
the bladder end. Electrohydraulic lithotripsy is the first
therapeutic choice for calcifications at the vesical end
of the stent [8], and this is what we used in our patient.
This case showed that a retained double-J stent
following gynecologic surgery can lead to significant
morbidity. Regarding the two causes of stone forma-
tion, the long period of retention seems to be more
critical than the properties of the material. For instance,
our patient developed a vesicovaginorectal stone.
We suggest close follow-up of inserted double-J stents
in order to prevent complications caused by retention.
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